| 货品编码 |
规格 |
纯度 |
价格 (¥) |
现价(¥) |
特价(¥) |
库存描述 |
数量 |
总计 (¥) |
| YZM001226-10mg |
10mg |
99.90% |
¥ 2252.00 |
¥ 2252.00 |
|
In-stock |
|
¥ 0.00 |
| YZM001226-5mg |
5mg |
99.90% |
¥ 1589.00 |
¥ 1589.00 |
|
In-stock |
|
¥ 0.00 |
| 10mg |
|
99.91% |
¥ 2250.00 |
¥ 2250.00 |
|
|
|
¥ 0.00 |
| 5mg |
|
99.91% |
¥ 1312.00 |
¥ 1312.00 |
|
|
|
¥ 0.00 |
| 中文别名 |
|
| 英文别名 |
|
| CAS号 |
206361-99-1 |
| SMILES |
O=C(O[C@@H]1[C@@]2([H])[C@@](OCC2)([H])OC1)N[C@@H](CC3=CC=CC=C3)[C@H](O)CN(S(=O)(C4=CC=C(N)C=C4)=O)CC(C)C |
| Inchi |
|
| InchiKey |
|
| 分子式 Molecular Weight |
C27H37N3O7S |
| 分子量 Formula |
547.66 |
| 闪点 FP |
|
| 熔点 Melting point |
|
| 沸点 Boiling point |
|
| 物理属性 Physical property |
|
| 密度 Density |
|
| 蒸汽压 Vapor Pressure |
|
| 溶解度Solubility |
生物体外In Vitro:DMSO溶解度≥ 100 mg/mL(182.60 mM)*"≥" means soluble可溶, but saturation unknown溶解度未知. |
| 化学性质Characters |
|
| 储藏条件 Storage conditions |
粉末Powder: -20°C 3 years年 4°C 2 years年 / In solvent溶液中:-80°C 6 months月 -20°C 1 month月 |
| 产品说明 |
|
| Introduction | Darunavir(TMC114) is an HIV protease inhibitor.
IC50 Value:
Target: HIV Protease
Darunavir HIV-1 antiviral structurally is similar to amprenavir and it is second generation HIV-1-protease inhibitor. Darunavir is a drug used to treat HIV infection. It is in the protease inhibitor class. Prezista is an OARAC recommended treatment option for treatment-naive and treatment-experienced adults and adolescents. |
| Application1 | |
| Application2 | |
| Application3 | |
Darunavir(TMC114) is an HIV protease inhibitor.
IC50 Value:
Target: HIV Protease
Darunavir HIV-1 antiviral structurally is similar to amprenavir and it is second generation HIV-1-protease inhibitor. Darunavir is a drug used to treat HIV infection. It is in the protease inhibitor class. Prezista is an OARAC recommended treatment option for treatment-naive and treatment-experienced adults and adolescents.
| 警示图 |
|
| 危险性 |
|
| 危险性警示 |
|
| 安全声明 |
|
| 安全防护 |
|
| 备注 |
|
购物车 
